STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Not yet recruiting
- Recurrent Acute Lymphoblastic Leukemia
- +7 more
- Biospecimen Collection
- (no location specified)
2021-11-17
Nov 17, 2021F
Recruiting
- Juvenile Myelomonocytic Leukemia
- +27 more
- CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
- +2 more
- Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
2022-03-16
Mar 16, 2022N
Not yet recruiting
- Myelodysplastic Syndrome
- +4 more
- UAE Inhibitor TAK-243
- (no location specified)
2022-03-25
Mar 25, 2022C
Terminated
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
- +8 more
- cytarabine
- +3 more
- Duarte, CaliforniaCity of Hope Medical Center
2022-03-28
Mar 28, 2022C
Active, not recruiting
- Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
- +18 more
- eltrombopag olamine
- Cleveland, OhioCase Comprehensive Cancer Center
2021-11-29
Nov 29, 2021U
Completed
- Recurrent Acute Leukemia of Ambiguous Lineage
- +5 more
- Chemosensitivity Assay
- +4 more
- Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
2021-12-17
Dec 17, 2021R
Completed
- Adult Acute Megakaryoblastic Leukemia (M7)
- +16 more
- choline magnesium trisalicylate
- +3 more
- New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
2021-08-20
Aug 20, 2021F
Recruiting
- Acute Lymphoblastic Leukemia
- +11 more
- Cyclosporine
- +8 more
- Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
2022-02-25
Feb 25, 2022C
Active, not recruiting
- Acute Myeloid Leukemia
- +5 more
- Decitabine
- +3 more
- Duarte, CaliforniaCity of Hope Medical Center
2022-02-17
Feb 17, 2022S
Active, not recruiting
- Leukemia
- Patient-derived CD22-specific CAR T-cells also expressing an EGFRt
- Seattle, WashingtonSeattle Children's Hospital
2022-02-15
Feb 15, 2022U
Recruiting
- Chronic Lymphocytic Leukemia
- +4 more
- Bobigny, France
- +8 more
2022-03-23
Mar 23, 2022N
Active, not recruiting
- Acute Lymphoblastic Leukemia
- +15 more
- Laboratory Biomarker Analysis
- +3 more
- Chicago, Illinois
- +2 more
2021-11-30
Nov 30, 2021A
Not yet recruiting
- Acute Lymphoblastic Leukemia
- complete blood count
- (no location specified)
2022-02-15
Feb 15, 2022N
Completed
- Leukemia
- Berkeley, CaliforniaUniversity of California, Berkeley
2022-04-07
Apr 7, 2022O
Recruiting
- Acute Leukemia
- +2 more
- Best Practice
- +2 more
- Columbus, OhioOhio State University Comprehensive Cancer Center
2021-10-25
Oct 25, 2021D
Active, not recruiting
- Relapsed Acute Lymphoblastic Leukemia (ALL)
- +8 more
- San Francisco, California
- +9 more
2022-01-03
Jan 3, 2022R
Terminated
- Adult Acute Megakaryoblastic Leukemia (M7)
- +15 more
- fludarabine phosphate
- +4 more
- New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
2021-08-20
Aug 20, 2021M
Recruiting
- Acute Bilineal Leukemia
- +5 more
- Houston, TexasM D Anderson Cancer Center
2021-09-30
Sep 30, 2021U
Recruiting
- Myelodysplastic Syndromes
- +2 more
- Ann Arbor, MichiganUniversity of Michigan Cancer Center
2022-03-31
Mar 31, 2022N
Recruiting
- Acute Myeloid Leukemia
- Taipei, TaiwanNational Taiwan University Hospital
2021-10-27
Oct 27, 2021M
Recruiting
- Acute Myeloid Leukemia
- +2 more
- Daratumumab/rHuPH20
- +3 more
- Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
2021-11-03
Nov 3, 2021N
Recruiting
- Chronic Lymphocytic Leukemia
- Taipei, TaiwanNational Taiwan University Hospital
2021-10-27
Oct 27, 2021W
Recruiting
- Recurrent Adult Acute Myeloid Leukemia
- Untreated Adult Acute Myeloid Leukemia
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
- Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
2021-12-21
Dec 21, 2021H
Recruiting
- CD7+ Acute Leukemia or Mixed Lineage Leukemia
- CD7 CART
- Beijing, Hebei, ChinaHe bei Yan da Lu dao pei Hospital
2021-06-16
Jun 16, 2021M
Recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +6 more
- Decitabine
- +2 more
- Houston, TexasM D Anderson Cancer Center
2022-02-25
Feb 25, 2022